Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2863 of 6351
-
Can cutting carbs help teens beat diabetes?
Disease control Recruiting nowThe purpose of this project is to test the effect of a low carb diet compared to standard carb diet among adolescents with T2D over a 24-week period.
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a simple injection cut blood transfusions in liver transplants?
Disease control Recruiting nowThis is a national multicenter, randomized clinical trial to evaluate the the efficacy and safety of DP administration in patients on the liver transplant waiting list to reduce intraoperative red blood cell concentrate transfusion.
Phase 3 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New device aims to quiet an overactive bladder without drugs
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a vaginal radiofrequency (RF) device called MORPHEUSV works to treat overactive bladder (OAB) in women. Researchers also want to learn how safe the device is for this indication. This study will include women ages 22 to 80 who have h…
Sponsor: InMode MD Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Ant venom allergy treatment: does it last?
Knowledge-focused Recruiting nowJack Jumper ant (JJA) venom allergy is a uniquely Australian medical condition. It is the leading cause of venom allergy and affects up to three per cent of the population. 70 percent of people with JJA allergy will have another reaction on a repeat sting and this sensitivity app…
Phase 4 • Sponsor: Murdoch Childrens Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
AI coaches students through back pain exercises at home
Symptom relief CompletedThis study tests whether an artificial intelligence (AI)-enhanced telerehabilitation program can effectively treat chronic non-specific low back pain in college students. Low back pain affects 40-52% of university students due to prolonged sitting during lectures and study sessi…
Sponsor: Majmaah University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
New study offers culturally tailored support for spanish-speaking families of autistic children
Symptom relief OngoingSupporting young autistic children can sometimes be very stressful, especially when children show behaviors that are difficult to understand and/or manage in everyday life. Research has shown that teaching parents practical strategies through programs like the Research Units in B…
Sponsor: Baylor University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Gut bacteria may hold key to slowing memory loss
Knowledge-focused Recruiting nowGlobally, populations are ageing increasing the prevalence of Alzheimer's disease (AD), due to lack of effective treatments. The traditional Mediterranean diet, rich in fibre and polyphenols (PPs) can help prevent or delay cognitive dysfunction and preserve healthy brain structur…
Sponsor: University of Ulster • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New drug stapokibart aims to ease stuffy nose in Non-Allergic rhinitis
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Stapokibart (CM310) works to treat Non-Allergic Rhinitis with Eosinophilia Syndrome (NARES) in adults. It will also learn about the safety of CM310. The main questions it aims to answer are: Does drug CM310 relieve the symptoms of …
Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a simple drug boost ECT for depressed teens?
Symptom relief Recruiting nowThe study design was a randomized, double blind, parallel controlled trial.The goal of this clinical trial is to learn if esketamine-assisted modified electroconvulsive therapy (ESK-MECT) works to treat severe depression in adolescents. It will also learn about the safety of ESK-…
Early phase 1 • Sponsor: Min Su • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Light vs. zaps: which works better for Bell's palsy?
Symptom relief Not yet recruitingDespite promising evidence supporting both photobiomodulation (PBM) and electrical stimulation (ES) in Bell's palsy rehabilitation, key gaps remain in the literature. Few studies have directly compared these modalities under standardized conditions, especially while keeping facia…
Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
New combo therapy aims to restore arm movement in stroke survivors
Symptom relief Recruiting nowThis study aims to evaluate the effectiveness of two rehabilitation techniques-Sensory Augmentation (using mirror therapy) and Neuromodulation (using transcranial direct current stimulation, tDCS)-in improving motor recovery among stroke survivors. Stroke often results in long-te…
Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New mRNA drug takes on HER2 cancers in first human trial
Disease control Recruiting nowThis clinical trial is designed to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of MT-304 in adults with advanced HER2-expressing solid tumors. The main questions it aims to answer are: * What is the safety profile of MT-304 when administered…
Phase 1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Kitchen spices meet science: can curcumin and CoQ10 gels stop mouth cancer before it starts?
Disease control Recruiting nowOral leukoplakia (OL) is recognized as the most common potentially malignant disorder of the oral mucosa. The pathogenesis of OL is complex and multifactorial, with oxidative stress playing a central role. Topical antioxidants have gained attention as therapeutic options to help …
Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New study tracks psoriasis Drug's Real-World impact on diverse skin types
Knowledge-focused Recruiting nowThis is a multi-centre, non-interventional, open-label, prospective observational study that will be conducted across Canada over 52-week duration. Approximately 80 patients who are initiating tildrakizumab as part of their routine care through the ILUMYA SUPPORT® Program and mee…
Sponsor: Chronicle Academy • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New combo therapy aims to tackle postpartum depression and incontinence without drugs
Symptom relief CompletedThe goal of this clinical trial is to evaluate if the combined treatment with EXOMIND (BTL-699-2) and EMSELLA (HPM-6000UF) devices is able to improve depressive symptoms and urinary incontinence in women who delivered a healthy, singleton infant 2-60 months before enrollment in t…
Sponsor: BTL Industries Ltd. • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Timing is everything: new study aims to find the best window to treat dangerous blood clots in the lungs
Knowledge-focused Recruiting nowPulmonary embolism (PE) is the third leading cause of cardiovascular mortality worldwide. Current guidelines recommend early reperfusion for high-risk and intermediate-high-risk PE, yet systemic thrombolysis and percutaneous therapies are frequently underutilized, and no specific…
Sponsor: Azienda ULSS 8 Berica • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
New drug may help pancreatic surgery patients recover faster
Symptom relief Recruiting nowExploring the effectiveness and safety of early use of Ariceptinfen after pancreaticoduodenectomy in alleviating postoperative pain and promoting recovery of patients. Main objective: To explore the analgesic effect of Anricfen after pancreaticoduodenectomy. Secondary objective…
Phase 2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Ear seeds and steroids: a new combo to beat chemo sickness?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if auricular point stimulation plus dexamethasone works to effectively prevent or suppress nausea and vomiting caused by docetaxel combined with cyclophosphamide in breast cancer adjuvant chemotherapy. It will also learn about the safet…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Ear seeds and steroids: a new combo to fight chemo sickness?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if auricular point stimulation plus dexamethasone works to effectively prevent or suppress nausea and vomiting caused by gemcitabine combined with paclitaxel protein-bound in pancreatic cancer treatment. It will also learn about the sa…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Ear seeds and steroids: a new combo to fight chemo nausea?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if auricular point stimulation plus dexamethasone works to effectively prevent or suppress nausea and vomiting caused by trastuzumab deruxtecan in breast cancer palliative therapy. It will also learn about the safety and influence on ga…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC